206 related articles for article (PubMed ID: 25349208)
1. Differential complement activation pathways promote C3b deposition on native and acetylated LDL thereby inducing lipoprotein binding to the complement receptor 1.
Klop B; van der Pol P; van Bruggen R; Wang Y; de Vries MA; van Santen S; O'Flynn J; van de Geijn GJ; Njo TL; Janssen HW; de Man P; Jukema JW; Rabelink TJ; Rensen PC; van Kooten C; Cabezas MC
J Biol Chem; 2014 Dec; 289(51):35421-30. PubMed ID: 25349208
[TBL] [Abstract][Full Text] [Related]
2. Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney.
Java A; Liszewski MK; Hourcade DE; Zhang F; Atkinson JP
Mol Immunol; 2015 Oct; 67(2 Pt B):584-95. PubMed ID: 26260209
[TBL] [Abstract][Full Text] [Related]
3. Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1.
Craig ML; Waitumbi JN; Taylor RP
J Immunol; 2005 Mar; 174(5):3059-66. PubMed ID: 15728520
[TBL] [Abstract][Full Text] [Related]
4. Complement receptor 1/CD35 is a receptor for mannan-binding lectin.
Ghiran I; Barbashov SF; Klickstein LB; Tas SW; Jensenius JC; Nicholson-Weller A
J Exp Med; 2000 Dec; 192(12):1797-808. PubMed ID: 11120776
[TBL] [Abstract][Full Text] [Related]
5. Complement receptor type 1 (CR1, CD35) is a receptor for C1q.
Klickstein LB; Barbashov SF; Liu T; Jack RM; Nicholson-Weller A
Immunity; 1997 Sep; 7(3):345-55. PubMed ID: 9324355
[TBL] [Abstract][Full Text] [Related]
6. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
[TBL] [Abstract][Full Text] [Related]
7. Activation, binding, and processing of complement component 3 (C3) by Blastomyces dermatitidis.
Zhang MX; Klein B
Infect Immun; 1997 May; 65(5):1849-55. PubMed ID: 9125571
[TBL] [Abstract][Full Text] [Related]
8. Cell surface expression of the C3b/C4b receptor (CR1) protects Chinese hamster ovary cells from lysis by human complement.
Makrides SC; Scesney SM; Ford PJ; Evans KS; Carson GR; Marsh HC
J Biol Chem; 1992 Dec; 267(34):24754-61. PubMed ID: 1447213
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcal protein Ecb impairs complement receptor-1 mediated recognition of opsonized bacteria.
Amdahl H; Haapasalo K; Tan L; Meri T; Kuusela PI; van Strijp JA; Rooijakkers S; Jokiranta TS
PLoS One; 2017; 12(3):e0172675. PubMed ID: 28273167
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of C3 by a casein kinase released from activated human platelets increases opsonization of immune complexes and binding to complement receptor type 1.
Nilsson-Ekdahl K; Nilsson B
Eur J Immunol; 2001 Apr; 31(4):1047-54. PubMed ID: 11298329
[TBL] [Abstract][Full Text] [Related]
11. Binding of submaximal C1q promotes complement-dependent cytotoxicity (CDC) of B cells opsonized with anti-CD20 mAbs ofatumumab (OFA) or rituximab (RTX): considerably higher levels of CDC are induced by OFA than by RTX.
Pawluczkowycz AW; Beurskens FJ; Beum PV; Lindorfer MA; van de Winkel JG; Parren PW; Taylor RP
J Immunol; 2009 Jul; 183(1):749-58. PubMed ID: 19535640
[TBL] [Abstract][Full Text] [Related]
12. Innate immune proteins C1q and mannan-binding lectin enhance clearance of atherogenic lipoproteins by human monocytes and macrophages.
Fraser DA; Tenner AJ
J Immunol; 2010 Oct; 185(7):3932-9. PubMed ID: 20833838
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the Putative Role of CR1 in Alzheimer's Disease: Genetic Association, Expression and Function.
Fonseca MI; Chu S; Pierce AL; Brubaker WD; Hauhart RE; Mastroeni D; Clarke EV; Rogers J; Atkinson JP; Tenner AJ
PLoS One; 2016; 11(2):e0149792. PubMed ID: 26914463
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.
Farries TC; Lachmann PJ; Harrison RA
Biochem J; 1988 May; 252(1):47-54. PubMed ID: 3421908
[TBL] [Abstract][Full Text] [Related]
15. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
Newman SL; Mikus LK
J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
[TBL] [Abstract][Full Text] [Related]
16. Reduced erythrocyte CR1 (CD 35) receptor function and complement opsonization in factor I-deficient patients is restored by plasma infusion.
Jepsen HH; Teisner B; Rasmussen JM; Svehag SE
Scand J Immunol; 1989 Feb; 29(2):247-55. PubMed ID: 2522236
[TBL] [Abstract][Full Text] [Related]
17. Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation.
Xu W; Berger SP; Trouw LA; de Boer HC; Schlagwein N; Mutsaers C; Daha MR; van Kooten C
J Immunol; 2008 Jun; 180(11):7613-21. PubMed ID: 18490764
[TBL] [Abstract][Full Text] [Related]
18. Proposed structure of the F' allotype of human CR1. Loss of a C3b binding site may be associated with altered function.
Wong WW; Farrell SA
J Immunol; 1991 Jan; 146(2):656-62. PubMed ID: 1670949
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of C4b dimer binding to distinct sites on the C3b/C4b receptor (CR1).
Reilly BD; Makrides SC; Ford PJ; Marsh HC; Mold C
J Biol Chem; 1994 Mar; 269(10):7696-701. PubMed ID: 8125996
[TBL] [Abstract][Full Text] [Related]
20. Binding of immune complexes to erythrocyte CR1 (CD35): difference in requirement of classical pathway components and indication of alternative pathway-mediated binding in C2-deficiency.
Klint C; Gullstrand B; Sturfelt G; Truedsson L
Scand J Immunol; 2000 Jul; 52(1):103-8. PubMed ID: 10886790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]